Increased 61 basis points to $14.12 per share. Efficiency Ratio -- Tax-equivalent efficiency ratio was 53.98%; adjusted ratio ...
Despite 30%+ margins and exposure to the GLP-1 opportunity, Natco Pharma continues to trade at a modest valuation. Is the 10x ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results